NASDAQ · Drug Manufacturers - Specialty & Generic

Lifecore Biomedical, Inc. (LFCR) Stock

$6.45 +0.31% NASDAQ: LFCR Healthcare

Valuation

MetricValue
Price$6.45
Market Cap$241.94M
P/E Ratio-5.95
P/B Ratio15.27
P/S Ratio2.00
EPS (TTM)$-1.27
52-Week High$8.98
52-Week Low$3.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-376.95%
ROA-16.25%
ROCE-1.25%
Gross Margin-13.18%
Operating Margin-13.18%
Net Margin-30.40%
Debt/Equity9.64
Current Ratio2.87

Annual Financials (USD)

Metric20222023202420252026
Revenue$111.0M$103.0M$128.0M$129.0M$129.0M
Operating Profit$-12.0M$-22.0M$-9.0M$-17.0M$-1.0M
Net Profit$-117.0M$-100.0M$12.0M$-39.0M$-31.0M
EPS$-3.97$-3.32$0.33$-1.27$-0.93
Op Margin-10.6%-21.1%-6.9%-13.4%-1.0%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$275.0M$254.0M$254.0M$239.0M$232.0M
Total Liabilities$187.0M$258.0M$243.0M$238.0M$246.0M
Cash$1.0M$19.0M$8.0M$8.0M$17.0M
Borrowings$248.0M$113.0M$134.0M$131.0M$143.0M

Latest News

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 15, 2026 Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market Insider Monkey · Jul 15, 2026 Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? Insider Monkey · Jun 30, 2026 Barrington Adjusts Price Target on Lifecore Biomedical to $6.50 From $6, Maintains Outperform Rating MT Newswires · Jun 16, 2026 Lifecore Biomedical Signs Deal to Support Manufacturing of Neurology Injection Product MT Newswires · Jun 15, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-23.0M$-17.0M$0$0$13.0M
Investing Cash Flow$50.0M$-26.0M$-37.0M$-20.0M$-8.0M
Financing Cash Flow$-2.0M$-6.0M$5.0M$1.0M$16.0M
Net Cash Flow$0$17.0M$-11.0M$0$0
Free Cash Flow$-53.0M$-39.0M$-18.0M$-14.0M$6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.48
EV / EBITDA-92.57
FCF Yield-0.73%
Quick Ratio2.69
Interest Coverage-0.09
Return 1Y-43.57%
Return 3Y-53.25%
Return 5Y-59.95%

Ownership

Insiders Held2.83%
Institutions Held77.25%
Institutions Float Held79.50%
Institutional HolderSharesReport Date
WYNNEFIELD CAPITAL INC4,703,2162026-03-31
Legion Partners Asset Management, LLC4,461,8232026-03-31
Greenhaven Road Investment Management, L.p.3,537,5732026-03-31
325 Capital Llc2,162,4662026-03-31
Blackrock Inc.1,877,3052026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACBAurora Cannabis Inc. $4.49 +1.35% -2.89 $278.12M 0.00%
ACHVAchieve Life Sciences, Inc. $7.41 +3.06% -4.67 $760.70M 0.00%
BIOABioAge Labs, Inc. $6.34 +2.09% -2.73 $238.70M 0.00%
CGCCanopy Growth Corporation $0.83 -2.33% -1.90 $349.16M 0.00%
CVRXCVRx, Inc. $1.58 -5.95% -0.78 $41.93M 0.00%

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc. is led by CEO Paul Josephs, publicly traded since 1996.

Lifecore Biomedical, Inc. (LFCR) stock trades at $6.45 with a market capitalization of $241.94M. The stock is valued at a price-to-earnings (P/E) ratio of -5.95, price-to-book of 15.27, price-to-sales of 2.00. Over the past 52 weeks the stock has ranged between $3.63 and $8.98, and currently trades 28.2% below its 52-week high.

On profitability, Lifecore Biomedical, Inc. generates a return on equity (ROE) of -376.95%, return on capital employed of -1.25%, an operating margin of -13.18%, a net profit margin of -30.40%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides